SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Walker, Andreas ^a,b   Skamel, Claudia ^a   Nassal, Michael ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; PROTEIN;

ARTICLE; CELL SURFACE DISPLAY; CHEMISTRY; METABOLISM; METHODOLOGY; PROTEIN CONFORMATION; ULTRASTRUCTURE; VIRION;

CELL SURFACE DISPLAY TECHNIQUES; NANOPARTICLES; PROTEIN CONFORMATION; PROTEINS; VIRION;

EID: 84860119495     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00005     Document Type: Article

References (59)

1. Young, M., Willits, D., Uchida, M. & Douglas, T. Plant viruses as biotemplates for materials and their use in nanotechnology. Annu Rev Phytopathol 46, 361-384 (2008).
2. Manchester, M. & Steinmetz, N. F. Viruses and nanotechnology. Preface. Curr Top Microbiol Immunol 327, v-vi (2009).
3. Steinmetz, N. F. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6, 634-641 (2010).
4. Plummer, E. M. & Manchester, M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol doi: 10. 1002/wnan. 119 (2010).
5. Whitacre, D. C., Lee, B. O. & Milich, D. R. Use of hepadnavirus core proteins as vaccine platforms. Expert Rev Vaccines 8, 1565-1573 (2009).
6. Crowther, R. A. et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77, 943-950 (1994). (Pubitemid 24187691)
7. Steven, A. C. et al. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. Adv Virus Res 64, 125-164 (2005). (Pubitemid 43583883)
8. Birnbaum, F. & Nassal, M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 64, 3319-3330 (1990). (Pubitemid 20219537)
9. Watts, N. R. et al. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. Embo J 21, 876-884 (2002). (Pubitemid 34206161)
10. Böttcher, B., Wynne, S. A. & Crowther, R. A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386, 88-91 (1997). (Pubitemid 27130926)
11. Conway, J. F. et al. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386, 91-94 (1997). (Pubitemid 27130927)
12. Wynne, S. A., Crowther, R. A. & Leslie, A. G. The crystal structure of the human hepatitis B virus capsid. Mol Cell 3, 771-780 (1999). (Pubitemid 29323055)
13. Salfeld, J., Pfaff, E., Noah, M. & Schaller, H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 63, 798-808 (1989). (Pubitemid 19057248)
14. Fehr, T., Skrastina, D., Pumpens, P. & Zinkernagel, R. M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci USA 95, 9477-9481 (1998). (Pubitemid 28506256)
15. Milich, D. R. & McLachlan, A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234, 1398-1401 (1986). (Pubitemid 17210220)
16. Pumpens, P. & Grens, E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44, 98-114 (2001). (Pubitemid 32757388)
17. Gregson, A. L. et al. Phase I trial of an alhydrogel adjuvanted hepatitis B core viruslike particle containing epitopes of Plasmodium falciparum circumsporozoite protein. PLoS One 3, e1556 (2008).
18. Taylor, K. M. et al. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. J Mol Recognit 13, 71-82 (2000). (Pubitemid 30257941)
19. Nassal, M. et al. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. Int J Med Microbiol 298, 135-142 (2008). (Pubitemid 350216556)
20. Ren, Z. J. et al. Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Sci 5, 1833-1843 (1996). (Pubitemid 26303487)
21. Sternberg, N. & Hoess, R. H. Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci USA 92, 1609-1613 (1995).
22. Kratz, P. A., Böttcher, B. & Nassal, M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 96, 1915-1920 (1999). (Pubitemid 29117842)
23. Steere, A. C. & Glickstein, L. Elucidation of Lyme arthritis. Nat Rev Immunol 4, 143-152 (2004). (Pubitemid 38209208)
24. Skamel, C. et al. Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J Biol Chem 281, 17474-17481 (2006).
25. Ormö, M. et al. Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392-1395 (1996). (Pubitemid 26296528)
26. Kumaran, D. et al. Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi. Embo J 20, 971-978 (2001). (Pubitemid 32186788)
27. Li, H., Dunn, J. J., Luft, B. J. & Lawson, C. L. Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab. Proc Natl Acad Sci USA 94, 3584-3589 (1997). (Pubitemid 27181472)
28. Nassal, M. et al. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 35, 655-665 (2005). (Pubitemid 40331342)
29. Walker, A., Skamel, C., Vorreiter, J. & Nassal, M. Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins. J Biol Chem 283, 33508-33515 (2008).
30. Kerppola, T. K. Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys 37, 465-487 (2008).
31. Salis, H. M., Mirsky, E. A. & Voigt, C. A. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol 27, 946-950 (2009).
32. Vogel, M., Vorreiter, J. & Nassal, M. Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins. Proteins 58, 478-488 (2005). (Pubitemid 40076061)
33. Porterfield, J. Z. et al. Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol 84, 7174-7184 (2010).
34. Böttcher, B., Vogel, M., Ploss, M. & Nassal, M. High plasticity of the hepatitis B virus capsid revealed by conformational stress. J Mol Biol 356, 812-822 (2006). (Pubitemid 43139340)
35. Conway, J. F. et al. Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. J Virol 77, 6466-6473 (2003). (Pubitemid 36588416)
36. Liu, S. et al. Removal of endotoxin from recombinant protein preparations. Clin Biochem 30, 455-463 (1997). (Pubitemid 27418541)
37. Zhong, W. et al. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci USA 94, 12533-12538 (1997). (Pubitemid 27492563)
38. Ding, W. et al. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. J Mol Biol 302, 1153-1164 (2000).
39. Casares, S., Brumeanu, T. D. & Richie, T. L. The RTS, S malaria vaccine. Vaccine 28, 4880-4894 (2010).
40. Milich, D. R., McLachlan, A., Thornton, G. B. & Hughes, J. L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329, 547-549 (1987). (Pubitemid 17124776)
41. Plassmeyer, M. L. et al. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284, 26951-26963 (2009).
42. Cerami, C. et al. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell 70, 1021-1033 (1992).
43. Billaud, J. N. et al. Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms. Vaccine 25, 1593-1606 (2007).
44. Cabantous, S., Terwilliger, T. C. & Waldo, G. S. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 23, 102-107 (2005). (Pubitemid 41724632)
45. Stiles, B. G., Garza, A. R., Ulrich, R. G. & Boles, J. W. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun 69, 2031-2036 (2001). (Pubitemid 32239666)
46. Jegerlehner, A. et al. Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrierspecific antibodies. Vaccine 28, 5503-5512 (2010).
47. De Filette, M. et al. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 26, 6503-6507 (2008).
48. Geldmacher, A. et al. A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies. Vaccine 23, 3973-3983 (2005). (Pubitemid 40726191)
49. Michnick, S. W., Ear, P. H., Manderson, E. N., Remy, I. & Stefan, E. Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat Rev Drug Discov 6, 569-582 (2007). (Pubitemid 47019445)
50. Lee, B. O. et al. Interaction of the hepatitis B core antigen and the innate immune system. J Immunol 182, 6670-6681 (2009).
51. Beterams, G., Böttcher, B. & Nassal, M. Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids. FEBS Lett 481, 169-176 (2000).
52. Popp, M. W., Antos, J. M., Grotenbreg, G. M., Spooner, E. & Ploegh, H. L. Sortagging: a versatile method for protein labeling. Nat Chem Biol 3, 707-708 (2007). (Pubitemid 47609111)
53. Finn, M. G. & Fokin, V. V. Click chemistry: function follows form. Chem Soc Rev 39, 1231-1232 (2010).
54. Strable, E. et al. Unnatural amino acid incorporation into virus-like particles. Bioconjug Chem 19, 866-875 (2008). (Pubitemid 351614542)
55. Manayani, D. J. et al. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 3, 1422-1431 (2007). (Pubitemid 350085607)
56. Nassal, M. Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization. Gene 66, 279-294 (1988).
57. Bichko, V. et al. Epitopes recognized by antibodies to denatured core protein of hepatitis B virus. Mol Immunol 30, 221-231 (1993).
58. Belnap, D. M. et al. Diversity of core antigen epitopes of hepatitis B virus. Proc Natl Acad Sci USA 100, 10884-10889 (2003). (Pubitemid 37140122)
59. Conway, J. F. et al. Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens. J Mol Biol 279, 1111-1121 (1998). (Pubitemid 28302388)